Literature DB >> 21555693

Breast cancer adjuvant therapy: time to consider its time-dependent effects.

Ismail Jatoi1, William F Anderson, Jong-Hyeon Jeong, Carol K Redmond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21555693      PMCID： PMC3107746          DOI： 10.1200/JCO.2010.32.3550

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  22 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

Review 2.  Time-dependent covariates in the Cox proportional-hazards regression model.

Authors:  L D Fisher; D Y Lin
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

3.  A parametric model for long-term follow-up data from phase III breast cancer clinical trials.

Authors:  Jong-Hyeon Jeong; Sin-Ho Jung; Samuel Wieand
Journal:  Stat Med       Date:  2003-02-15       Impact factor: 2.373

4.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

5.  Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.

Authors:  R Demicheli; R Miceli; A Moliterni; M Zambetti; W J M Hrushesky; M W Retsky; P Valagussa; G Bonadonna
Journal:  Ann Oncol       Date:  2005-06-14       Impact factor: 32.976

6.  Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.

Authors:  William F Anderson; Ismail Jatoi; Susan S Devesa
Journal:  Breast Cancer Res Treat       Date:  2005-03       Impact factor: 4.872

7.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

8.  Hazard rates of recurrence following diagnosis of primary breast cancer.

Authors:  Ismail Jatoi; Anna Tsimelzon; Heidi Weiss; Gary M Clark; Susan G Hilsenbeck
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

9.  Hazard function estimation using B-splines.

Authors:  P S Rosenberg
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

Review 10.  Improved endpoints for cancer immunotherapy trials.

Authors:  Axel Hoos; Alexander M M Eggermont; Sylvia Janetzki; F Stephen Hodi; Ramy Ibrahim; Aparna Anderson; Rachel Humphrey; Brent Blumenstein; Lloyd Old; Jedd Wolchok
Journal:  J Natl Cancer Inst       Date:  2010-09-08       Impact factor: 13.506
View more
  67 in total

1.  Simulation of Chemotherapy Effects in Older Breast Cancer Patients With High Recurrence Scores.

Authors:  Young Chandler; Jinani C Jayasekera; Clyde B Schechter; Claudine Isaacs; Christopher J Cadham; Jeanne S Mandelblatt
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

2.  Factors associated with pregnancy attempts among female young adult cancer survivors.

Authors:  Sally A Dominick; Brian W Whitcomb; Jessica R Gorman; Jennifer E Mersereau; Karine Chung; H Irene Su
Journal:  J Cancer Surviv       Date:  2014-05-24       Impact factor: 4.442

3.  The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.

Authors:  Debra A Goldman; Koos Hovinga; Anne S Reiner; Yoshua Esquenazi; Viviane Tabar; Katherine S Panageas
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

4.  Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Authors:  Diego Munoz; Aimee M Near; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Oguzhan Alagoz; Donald A Berry; Elizabeth S Burnside; Yaojen Chang; Gary Chisholm; Harry J de Koning; Mehmet Ali Ergun; Eveline A M Heijnsdijk; Hui Huang; Natasha K Stout; Brian L Sprague; Amy Trentham-Dietz; Jeanne S Mandelblatt; Sylvia K Plevritis
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

5.  Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.

Authors:  Ismail Jatoi; Hanna Bandos; Jong-Hyeon Jeong; William F Anderson; Edward H Romond; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2015-10-30       Impact factor: 13.506

6.  The overall survival of breast cancer patients without adjuvant therapy.

Authors:  Sakura Onishi; Masataka Sawaki; Junko Ishiguro; Ayumi Kataoka; Madoka Iwase; Kayoko Sugino; Yayoi Adachi; Naomi Gondo; Haruru Kotani; Akiyo Yoshimura; Masaya Hattori; Keitaro Matsuo; Yasushi Yatabe; Hiroji Iwata
Journal:  Surg Today       Date:  2019-02-07       Impact factor: 2.549

7.  A Cell-Permeable Stapled Peptide Inhibitor of the Estrogen Receptor/Coactivator Interaction.

Authors:  Thomas E Speltz; Jeanne M Danes; Joshua D Stender; Jonna Frasor; Terry W Moore
Journal:  ACS Chem Biol       Date:  2018-01-24       Impact factor: 5.100

8.  Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.

Authors:  Adeniyi Francis Fagbamigbe; Emma Norrman; Christina Bergh; Ulla-Britt Wennerholm; Max Petzold
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

9.  Vimentin as a poor prognostic factor for triple-negative breast cancer.

Authors:  Nami Yamashita; Eriko Tokunaga; Hiroyuki Kitao; Yuichi Hisamatsu; Kenji Taketani; Sayuri Akiyoshi; Satoko Okada; Shinichi Aishima; Masaru Morita; Yoshihiko Maehara
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-26       Impact factor: 4.553

10.  Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era.

Authors:  Erin M Olson; Julie S Najita; Jessica Sohl; Amal Arnaout; Harold J Burstein; Eric P Winer; Nancy U Lin
Journal:  Breast       Date:  2013-01-23       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.